Larimar Therapeutics
LRMR
#8139
Rank
C$0.47 B
Marketcap
C$4.50
Share price
-2.48%
Change (1 day)
-10.30%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): C-$2.71

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is C-$2.80. In 2025 the company made an earnings per share (EPS) of C-$3.17 a decrease over its 2024 EPS that were of C-$1.86.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$2.71-14.61%
2025C-$3.1770%
2024C-$1.86
2022C-$2.21-48.15%
2021C-$4.26-14.27%
2020C-$4.97